Posted in

Haryana HPV vaccination drive doubles coverage in 10 days

Doctor preparing a patient for a hair restoration procedure, illustrating practical applications in dermatology subspecialisation.

The HPV vaccination Haryana campaign has demonstrated a remarkable shift in momentum recently. Within a brief ten-day review period, the state’s total coverage doubled from 6% to 12%. This progress reflects a concerted effort by health officials to address initial delays. Consequently, the vaccination drive is now reaching thousands of eligible adolescents across various districts, highlighting the importance of a structured adolescent health program in public health strategy.

Progress in the HPV vaccination Haryana rollout

According to the latest UWIN data, health workers have vaccinated 27,227 adolescent girls aged 14\u201315. This figure represents progress toward an overall state target of 2.26 lakh beneficiaries. While the state average stands at 12%, local performance varies significantly between districts. For instance, Karnal and Yamunanagar are currently leading with 37% and 35% coverage, respectively. Gurgaon has also shown improvement, reaching 10% coverage with over 1,600 cumulative doses administered.

However, some regions continue to face challenges in uptake. Specifically, districts like Jind, Hisar, and Jhajjar report coverage rates between 3% and 4%. To address these gaps, officials are intensifying school-based mobilisation and field outreach. They are also utilizing ASHA and anganwadi workers to identify out-of-school girls. This strategy aims to ensure that no eligible beneficiary is missed during the intensive three-month window, reflecting the clinical rigour taught in specialized paediatric practice.

Addressing Hesitancy and Clinical Goals

Identifying the root causes of slow progress was a primary focus for the state steering committee. Officials noted that vaccine hesitancy and misinformation were significant hurdles during the early phases. Furthermore, weak inter-departmental coordination initially slowed the campaign’s rollout. In response, authorities have directed schools and local bodies to widen their outreach efforts. These teams are working hard to dispel myths associated with the vaccine’s safety.

Early vaccination is vital because nearly all cervical cancer cases are linked to persistent HPV infections. India accounts for approximately 79,000 new cases and 35,000 deaths annually due to this disease. Therefore, achieving high coverage among 14-year-olds is a critical public health priority. The current campaign utilizes a single-dose strategy, which is both safe and effective for long-term prevention. Maintaining this increased momentum remains essential as the campaign window nears its conclusion, a focus shared by those pursuing a certification course in clinical oncology.

Frequently Asked Questions

Q1: What is the specific target group for the current vaccination drive in Haryana?

The campaign primarily targets adolescent girls between the ages of 14 and 15 years to ensure protection before exposure to the virus.

Q2: How are health officials tracking the progress of the vaccination campaign?

Authorities use the digital UWIN platform to monitor real-time data on doses administered and coverage across different districts.

Q3: Why is the focus on schools for the vaccine rollout?

Schools serve as a central hub for identifying eligible girls and facilitating parental consent, making the rollout more efficient and structured.

References

  1. HPV vaccination coverage doubles to 12% in 10 days in Haryana, Gurgaon at 10% – ETHealthworld
  2. India May Avert 10 Million Cervical Cancer but Vaccine Cover Remains Low – The Indian Express
  3. India Launches Nationwide HPV Vaccination Campaign for Adolescent Girls – Gavi

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.

Leave a Reply

Your email address will not be published. Required fields are marked *